Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement
The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has played an integral role in educating both the metabolic surgical and the medical community at large about the role of innovative and new surgical and/or endoscopic interventions in treating adiposity-based chronic diseases.
The mini gastric bypass is also known as the one anastomosis gastric bypass. The IFSO has agreed that the standard nomenclature should be the mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB). The IFSO commissioned a task force (Appendix 1) to determine if MGB-OAGB is an effective and safe procedure and if it should be considered a surgical option for the treatment of obesity and metabolic diseases.
The following position statement is issued by the IFSO MGB-OAGB task force and approved by the IFSO Scientific Committee and Executive Board. This statement is based on current clinical knowledge, expert opinion, and published peer-reviewed scientific evidence. It will be reviewed in 2 years.
KeywordsMGB OAGB IFSO Position statement Systematic Review
Compliance with Ethical Standards
Dr. De Luca has nothing to disclose. Ms. Tie reports personal fees from Centre for Obesity Research and Education (CORE), grants from Apollo Endosurgery, grants from Novo Nordisc, outside the submitted work. Dr. Ooi reports personal fees from National Health and Medical Research Council, personal fees from Royal Australasian College of Surgeon, outside the submitted work. Dr. Himpens reports personal fees from Ethicon, personal fees from Medtronic, outside the submitted work. Dr. Higa has nothing to disclose. Dr. Carbajo reports he is the current President of the MGB-OAGB International Club. Dr. Mahawar reports he has been paid honoraria by Medtronic Inc. for mentoring consultant bariatric surgeons in the United Kingdom to help them start them start their One Anastomosis Gastric Bypass programme. Dr Shikora has nothing to disclose. Dr. Brown reports grants from Johnson and Johnson, grants from Medtronic, grants from GORE, personal fees from GORE, grants from Applied Medical, grants from Apollo Endosurgery, grants and personal fees from Novo Nordisc, personal fees from Merck Sharpe and Dohme, outside the submitted work.
Ethical approval is not required for this type of study.
Informed consent is not required for this study.
- 7.Angrisani, L., et al., Bariatric surgery and Endoluminal procedures: IFSO worldwide survey 2014. Obes Surg, 2017.Google Scholar
- 14.Greco, F. and R. Tacchino, Ileal food diversion: a simple, powerful and easily revisable and reversible single-anastomosis gastric bypass. Obes Surg, 2014. 19.Google Scholar
- 15.Kaska L, Proczko M, Wiśniewski P, et al. A prospective evaluation of the influence of three bariatric procedures on insulin resistance improvement. Should the extent of undiluted bile transit be considered a key postoperative factor altering glucose metabolism? Wideochir Inne Tech Maloinwazyjne. 2015;10(2):213–28.PubMedPubMedCentralGoogle Scholar
- 22.Shenouda, M.M., et al., Bile gastritis following laparoscopic single anastomosis gastric bypass: pilot study to assess significance of bilirubin level in gastric aspirate. Obes Surg, 2017.Google Scholar
- 31.Guo, X., et al., [Impacts of laparoscopic bariatric surgery on GLP-1 and Ghrelin level in patients with type 2 diabetes mellitus]. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery], 2013. 51(4): p. 323–7.Google Scholar
- 47.Carbajo MA, Jiménez JM, Castro MJ, et al. Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass. Nutricion Hospitalaria. 2014;30(5):1032–8.PubMedGoogle Scholar
- 50.Musella, M., et al., A decade of bariatric surgery. What have we learned? Outcome in 520 patients from a single institution. International Journal Of Surgery, 2014. 12 Suppl 1: p. S183–8.Google Scholar
- 60.Kansou, G., et al., Laparoscopic sleeve gastrectomy versus laparoscopic mini gastric bypass: One year outcomes. International Journal Of Surgery, 2016. 33 Pt A: p. 18–22.Google Scholar
- 62.Musella M, Apers J, Rheinwalt K, et al. Efficacy of bariatric surgery in type 2 diabetes mellitus remission: the role of mini gastric bypass/one anastomosis gastric bypass and sleeve Gastrectomy at 1 year of follow-up. A European survey Obesity Surgery. 2016;26(5):933–40.CrossRefPubMedGoogle Scholar
- 63.Karimi, M., et al., Trend of changes in serum albumin and its relation with sex, age, and BMI following laparoscopic mini-gastric bypass surgery in morbid obese cases. Obes Surg, 2017.Google Scholar
- 91.Mishra T, Lakshmi KK, Peddi KK. Prevalence of cholelithiasis and choledocholithiasis in morbidly obese south Indian patients and the further development of biliary calculus disease after sleeve gastrectomy, gastric bypass and mini gastric bypass. Obes Surg. 2016;26(10):2411–7.CrossRefPubMedGoogle Scholar